Home Applications 088365 Application 088365
Type ANDA
Sponsor HIKMA PHARMS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 CHLOROTHIAZIDE AND RESERPINE CHLOROTHIAZIDE; RESERPINE TABLET;ORAL 500MG;0.125MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A088365-001 CHLOROTHIAZIDE AND RESERPINE CHLOROTHIAZIDE; RESERPINE 500MG;0.125MG TABLET / ORAL 1983-12-22 A088365-002 CHLOROTHIAZIDE AND RESERPINE CHLOROTHIAZIDE; RESERPINE 250MG;0.125MG TABLET / ORAL 1983-12-22
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 49 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A088365-001 CHLOROTHIAZIDE AND RESERPINE 500MG;0.125MG TABLET / ORAL 1983-12-22 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A088365-001 CHLOROTHIAZIDE AND RESERPINE 500MG;0.125MG TABLET / ORAL 1983-12-22 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A088365-001 CHLOROTHIAZIDE AND RESERPINE 500MG;0.125MG TABLET / ORAL 1983-12-22 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A088365-001 CHLOROTHIAZIDE AND RESERPINE 500MG;0.125MG TABLET / ORAL 1983-12-22 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A088365-001 CHLOROTHIAZIDE AND RESERPINE 500MG;0.125MG TABLET / ORAL 1983-12-22 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A088365-001 CHLOROTHIAZIDE AND RESERPINE 500MG;0.125MG TABLET / ORAL 1983-12-22 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A088365-001 CHLOROTHIAZIDE AND RESERPINE 500MG;0.125MG TABLET / ORAL 1983-12-22 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A088365-001 CHLOROTHIAZIDE AND RESERPINE 500MG;0.125MG TABLET / ORAL 1983-12-22 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A088365-001 CHLOROTHIAZIDE AND RESERPINE 500MG;0.125MG TABLET / ORAL 1983-12-22 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.